Return to Today's science sparks archives

2021-01-04

FIGURE 1: Pellets of HEK293 cells transfected with SARS-CoV2: S1 and S2 subunit of spike protein, nucleoprotein and untransfected cells.

FIGURE 1: Pellets of HEK293 cells transfected with SARS-CoV2: S1 and S2 subunit of spike protein, nucleoprotein and untransfected cells.
  • Szabolcs M, Sauter JL, Frosina D, Geronimo JA, Hernandez E, Selbs E, Rapkiewicz AV, Rekhtman N, Baine MK, Jager E, Travis WD, Jungbluth AA

  • Appl Immunohistochem Mol Morphol. 2021 Jan;29(1):5-12. doi: 10.1097/PAI.0000000000000878.
Open Access button

2021-01-05

Figure 1. Current nanotherapies available for paclitaxel delivery in NSCLC

Figure 1. Current nanotherapies available for paclitaxel delivery in NSCLC
  • Jee J, Li BT

  • Ann Oncol. 2021 Jan;32(1):9-11. doi: 10.1016/j.annonc.2020.11.010. Epub 2020 Nov 22.

2021-01-06

FIGURE 4. Case 9: Pancreas biopsy showing a HG-NEN (A, hematoxylin and eosin) with proliferation index of 90% (B, Ki67).

FIGURE 4. Case 9: Pancreas biopsy showing a HG-NEN (A, hematoxylin and eosin) with proliferation index of 90% (B, Ki67).
  • Vyas M, Tang LH, Rekhtman N, Klimstra DS

  • Am J Surg Pathol. 2021 Jan;45(1):25-34. doi: 10.1097/PAS.0000000000001602.

2021-01-07

Figure 1. Geographic distribution of cases reported to the ASH Research Collaborative COVID-19 Registry for Hematology (n = 248).

Figure 1. Geographic distribution of cases reported to the ASH Research Collaborative COVID-19 Registry for Hematology (n = 248).
  • Wood WA, Neuberg DS, Thompson JC, Tallman MS, Sekeres MA, Sehn LH, Anderson KC, Goldberg AD, Pennell NA, Niemeyer CM, Tucker E, Hewitt K, Plovnick RM, Hicks LK

  • Blood Adv. 2020 Dec 8;4(23):5966-5975.
Open Access button

2021-01-08

Visual Abstract.

Visual Abstract.
  • Barker JN, Devlin SM, Naputo KA, Skinner K, Maloy MA, Flynn L, Anagnostou T, Avecilla ST, Scaradavou A, Cho C, Dahi PB, Giralt SA, Gyurkocza B, Hanash AM, Hsu K, Jakubowski AA, Papadopoulos EB, Peled JU, Perales MA, Sauter CS, Shah GL, Shaffer BC, Tamari R, Young JW, Roshal M, O'Reilly RJ, Ponce DM, Politikos I

  • Blood Adv. 2020 Dec 8;4(23):6064-6076.
Open Access button

2021-01-11

Figure 1. Schematic of EGFR and its downstream pathways with monoclonal antibodies exerting their effects at the extracellular domain, and small molecule inhibitors inhibiting phosphorylation intracellularly.

Figure 1. Schematic of EGFR and its downstream pathways with monoclonal antibodies exerting their effects at the extracellular domain, and small molecule inhibitors inhibiting phosphorylation intracellularly.
  • Maron SB, Xu J, Janjigian YY

  • Front Oncol. 2020 Dec 8;10:553876.
Open Access button

2021-01-12

Visual Abstract.

Visual Abstract.
  • Xiao W, Miles LA, Bowman RL, Durani V, Tian HS, DelGaudio NL, Mishra T, Zhu M, Zhang Y, Stump SE, Tallman MS, Levine RL, Cai SF

  • Blood Adv. 2020 Dec 8;4(23):6034-6038.
Open Access button

2021-01-13

Visual Abstract

Visual Abstract
  • Wudhikarn K, Mailankody S, Smith EL

  • Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):272-279. doi: 10.1182/hematology.2020000111.
Open Access button

2021-01-14

Graphical Abstract.

Graphical Abstract.
  • Trinchant NM, MacKay MJ, Chin C, Afshinnekoo E, Foox J, Meydan C, Butler D, Mozsary C, Vernice NA, Darby C, Schatz MC, Bailey SM, Melnick AM, Guzman M, Bolton K, Braunstein LZ, Garrett-Bakelman F, Levine RL, Hassane D, Mason CE

  • Cell Rep. 2020 Dec 8;33(10):108458. doi: 10.1016/j.celrep.2020.108458. Epub 2020 Nov 25.
Open Access button

2021-01-15

Fig. 1. Durvalumab plus tremelimumab combination therapy with or without paclitaxel administration schedule.

Fig. 1. Durvalumab plus tremelimumab combination therapy with or without paclitaxel administration schedule.
  • Boileve A, Hilmi M, Gougis P, Cohen R, Rousseau B, Blanc JF, Ben Abdelghani M, Castanie H, Dahan L, Tougeron D, Metges JP, Tournigand C, Garcia-Larnicol ML, Vernerey D, Turpin A, Neuzillet C

  • Eur J Cancer. 2020 Dec 3;143:55-63. doi: 10.1016/j.ejca.2020.10.027.

2021-01-19

Fig. 4 Tumor mutational burden (a), copy-number burden (b), and FACETS-derived tumor ploidy (c) stratified by FGFR3-TACC3 fusion status.

Fig. 4 Tumor mutational burden (a), copy-number burden (b), and FACETS-derived tumor ploidy (c) stratified by FGFR3-TACC3 fusion status.
  • Mata DA, Benhamida JK, Lin AL, Vanderbilt CM, Yang SR, Villafania LB, Ferguson DC, Jonsson P, Miller AM, Tabar V, Brennan CW, Moss NS, Sill M, Benayed R, Mellinghoff IK, Rosenblum MK, Arcila ME, Ladanyi M, Bale TA

  • Acta Neuropathol Commun. 2020 Nov 9;8(1):186. doi: 10.1186/s40478-020-01058-6.
Open Access button

2021-01-20

Figure 1: Molecular sub-classification of GIST

Figure 1: Molecular sub-classification of GIST
  • Kelly CM, Gutierrez Sainz L, Chi P

  • J Hematol Oncol. 2021 Jan 5;14(1):2. doi: 10.1186/s13045-020-01026-6.
Open Access button

2021-01-21

Figure 2: LXRβ-deficient T cells are competitively unfit.

Figure 2: LXRβ-deficient T cells are competitively unfit.
  • Michaels AJ, Campbell C, Bou-Puerto R, Rudensky AY

  • J Exp Med. 2021 Apr 5;218(4). pii: 211640. doi: 10.1084/jem.20201311.

2021-01-25

Figure 1: Chemical modification scheme of pristine CNC to yield iodo- and ammonium-functionalized fCNC.

Figure 1: Chemical modification scheme of pristine CNC to yield iodo- and ammonium-functionalized fCNC.
  • Wong S, Alidori S, Mello BP, Almeida BA, Ulmert D, Brendel MB, Scheinberg DA, McDevitt MR

  • Sci Rep. 2021 Jan 8;11(1):157. doi: 10.1038/s41598-020-79592-5.
Open Access button

2021-01-26

Figure 1. Trial Schema for the NCI-MATCH

Figure 1. Trial Schema for the NCI-MATCH
  • Murciano-Goroff YR, Drilon A, Stadler ZK

  • Cancer Cell. 2021 Jan 11;39(1):22-24. doi: 10.1016/j.ccell.2020.12.021.

2021-01-28

Fig. 5. Visualization of activations of the generator network.

Fig. 5. Visualization of activations of the generator network.
  • Tan J, Jing L, Huo Y, Li L, Akin O, Tian Y

  • Comput Med Imaging Graph. 2020 Nov 16;87:101817. doi: 10.1016/j.compmedimag.2020.101817.
Open Access button

2021-01-29

Visual Abstract

Visual Abstract
  • Bobillo S, Joffe E, Lavery JA, Sermer D, Ghione P, Noy A, Caron PC, Hamilton AM, Hamlin PA, Horwitz SM, Kumar A, Matasar MJ, Moskowitz AJ, Owens C, Palomba ML, Batlevi C, Straus DJ, von Keudell G, Zelenetz AD, Yahalom J, Dogan A, Seshan VE, Younes A

  • Blood. 2020 Jul 30. pii: 461623. doi: 10.1182/blood.2020005112.
Open Access button

2021-02-01

Fig. 1: Structure determination of CARD8-CT and NLRP1-CT filaments.

Fig. 1: Structure determination of CARD8-CT and NLRP1-CT filaments.
  • Robert Hollingsworth L, David L, Li Y, Griswold AR, Ruan J, Sharif H, Fontana P, Orth-He EL, Fu TM, Bachovchin DA, Wu H

  • Nat Commun. 2021 Jan 8;12(1):189. doi: 10.1038/s41467-020-20320-y.
Open Access button

2021-02-02

Fig 1. Coagulation and fibrinolytic cascades and the mechanisms of hemostatic agents.

Fig 1. Coagulation and fibrinolytic cascades and the mechanisms of hemostatic agents.
  • Park JA

  • Int J Mol Sci. 2021 Jan 14;22(2). pii: ijms22020793. doi: 10.3390/ijms22020793.
Open Access button

2021-02-03

Fig 1. Survey on training in Upper GI of young surgeons: participants world map

Fig 1. Survey on training in Upper GI of young surgeons: participants world map
  • Reddavid R, Allum W, Polom K, Resendiz A, Hyung WJ, Kassab P, Molena D, Lanzarini E, Terashima M, Biondi A, Hilegersberg RV, D'Ugo D, Fumagalli U, Santi S, De Manzoni G, Roviello F, Degiuli M

  • Updates Surg. 2021 Jan 8. pii: 10.1007/s13304-020-00955-8. doi: 10.1007/s13304-020-00955-8.

2021-02-04

Fig 1. Mutation spectra in mucosal and common cutaneous melanomas.

Fig 1. Mutation spectra in mucosal and common cutaneous melanomas.
  • Mundra PA, Dhomen N, Rodrigues M, Mikkelsen LH, Cassoux N, Brooks K, Valpione S, Reis-Filho JS, Heegaard S, Stern MH, Roman-Roman S, Marais R

  • Nat Commun. 2021 Jan 11;12(1):259. doi: 10.1038/s41467-020-20432-5.
Open Access button

2021-02-05

Figure 2. Anatomic lung segments and 7 study groupings (4 left, 3 right).

Figure 2. Anatomic lung segments and 7 study groupings (4 left, 3 right).
  • Jones GD, Caso R, Choe G, Tan KS, Connolly JG, Dycoco J, Molena D, Park BJ, Huang J, Adusumilli PS, Bott MJ, Downey RJ, Travis WD, Jones DR, Rocco G

  • Ann Thorac Surg. 2020 Jul 31. pii: S0003-4975(20)31223-6. doi: 10.1016/j.athoracsur.2020.05.166.

2021-02-08

Figure 4. Effects of cGAMP Transport in the Tumor Microenvironment.

Figure 4. Effects of cGAMP Transport in the Tumor Microenvironment.
  • Vashi N, Bakhoum SF

  • Trends Biochem Sci. 2021 Jan 15. pii: S0968-0004(20)30322-4. doi: 10.1016/j.tibs.2020.12.010.

2021-02-09

Fig 2. Motion compensation on automatic tumor supplying vessels performance.

Fig 2. Motion compensation on automatic tumor supplying vessels performance.
  • Ridouani F, Doustaly R, Yarmohammadi H, Solomon SB, Gonzalez-Aguirre AJ

  • Cardiovasc Intervent Radiol. 2021 Jan 20. pii: 10.1007/s00270-021-02767-8. doi: 10.1007/s00270-021-02767-8.

2021-02-10

Figure 2. Candidate mechanisms of tandem duplication formation in BRCA1-deficient cells.

Figure 2. Candidate mechanisms of tandem duplication formation in BRCA1-deficient cells.
  • Setton J, Reis-Filho JS, Powell SN

  • Curr Opin Genet Dev. 2021 Jan 18;66:93-100. doi: 10.1016/j.gde.2021.01.002.

2021-02-11

Figure 4. Musashi expression in dispersed anterior pituitary (AP) cell lineages.

Figure 4. Musashi expression in dispersed anterior pituitary (AP) cell lineages.
  • Allensworth-James M, Banik J, Odle A, Hardy L, Lagasse A, Moreira ARS, Bird J, Thomas CL, Avaritt N, Kharas MG, Lengner CJ, Byrum SD, MacNicol MC, Childs GV, MacNicol AM

  • Endocrinology. 2021 Mar 1;162(3). pii: 6054984.

2021-02-12

Figure 3. Pairwise single-nucleotide variant comparison between spatially linked multilocus sequence typing concordant post-discharge (PD) cases and putative donors.

Figure 3. Pairwise single-nucleotide variant comparison between spatially linked multilocus sequence typing concordant post-discharge (PD) cases and putative donors.
  • Babady NE, Aslam A, McMillen T, Syed M, Zehir A, Kamboj M

  • J Hosp Infect. 2020 Nov 7;109:96-100.

2021-02-15

Fig. 2. Cross-validation of the DNA methylation-based sarcoma classifier.

Fig. 2. Cross-validation of the DNA methylation-based sarcoma classifier.
  • Koelsche C, Schrimpf D, Stichel D, Sill M, Sahm F, Reuss DE...von Deimling A

  • Nat Commun. 2021 Jan 21;12(1):498.
Open Access button

2021-02-16

Figure 3: Distribution of image count per patient.

Figure 3: Distribution of image count per patient.
  • Rotemberg V, Kurtansky N, Betz-Stablein B, Caffery L, Chousakos E, Codella N, Combalia M, Dusza S, Guitera P, Gutman D, Halpern A, Helba B, Kittler H, Kose K, Langer S, Lioprys K, Malvehy J, Musthaq S, Nanda J, Reiter O, Shih G, Stratigos A, Tschandl P, Weber J, Soyer HP

  • Sci Data. 2021 Jan 28;8(1):34.
Open Access button

2021-02-17

Fig 1. Deletion of CIS in CAR-NK cells enhances IL-15 signaling by removing an immune checkpoint, which leads to increased activation of the AKT/mTOR pathway and, in the presence of tumor cells, enhanced c-Myc activation.

Fig 1. Deletion of CIS in CAR-NK cells enhances IL-15 signaling by removing an immune checkpoint, which leads to increased activation of the AKT/mTOR pathway and, in the presence of tumor cells, enhanced c-Myc activation.
  • Chen S

  • Blood. 2021 Feb 4;137(5):579-581.

2021-02-18

Fig 1. Proposed mechanisms of NLRP1 activation.

Fig 1. Proposed mechanisms of NLRP1 activation.
  • Bachovchin DA

  • Mol Cell. 2021 Feb 4;81(3):423-425.

2021-02-19

Graphical Abstract

Graphical Abstract
  • Litchfield K, Reading JL, Puttick C, Thakkar K, Abbosh C, Bentham R, Watkins TBK, Rosenthal R, Biswas D, Rowan A, Lim E, Al Bakir M, Turati V, Guerra-Assunção JA, Conde L, Furness AJS, Saini SK, Hadrup SR, Herrero J, Lee SH, Van Loo P, Enver T, Larkin J, Hellmann MD, Turajlic S, Quezada SA, McGranahan N, Swanton C

  • Cell. 2021 Feb 4;184(3):596-614.e14.

2021-02-22

Fig 1. Tissue damage induces cancer-associated chromatin states in pre-malignancy.

Fig 1. Tissue damage induces cancer-associated chromatin states in pre-malignancy.
  • Alonso-Curbelo D, Ho YJ, Burdziak C, Maag JLV, Morris JP 4th, Chandwani R, Chen HA, Tsanov KM, Barriga FM, Luan W, Tasdemir N, Livshits G, Azizi E, Chun J, Wilkinson JE, Mazutis L, Leach SD, Koche R, Pe'er D, Lowe SW

  • Nature. 2021 Feb 3.

2021-02-23

Visual Abstract

Visual Abstract
  • Morschhauser F, Feugier P, Flinn IW, Gasiorowski R, Greil R, Illes A, Johnson NA, Larouche JF, Lugtenburg PJ, Patti C, Salles GA, Trneny M, de Vos S, Mir F, Samineni D, Kim SY, Jiang Y, Punnoose E, Sinha A, Clark E, Spielewoy N, Humphrey K, Bazeos A, Zelenetz AD

  • Blood. 2020 Sep 21:blood.2020006578.

2021-02-24

Figure 3: Input and outputs of TWOMBLI pipeline.

Figure 3: Input and outputs of TWOMBLI pipeline.
  • Wershof E, Park D, Barry DJ, Jenkins RP, Rullan A, Wilkins A, Schlegelmilch K, Roxanis I, Anderson KI, Bates PA, Sahai E

  • Life Sci Alliance. 2021 Jan 27;4(3). pii: 4/3/e202000880. doi: 10.26508/lsa.202000880. Print 2021 Mar.
Open Access button

2021-02-25

Graphical abstract

Graphical abstract
  • Helou L, Beauclair L, Dardente H, Piegu B, Tsakou-Ngouafo L, Lecomte T, Kentsis A, Pontarotti P, Bigot Y

  • J Mol Biol. 2021 Feb 2;433(7):166839. doi: 10.1016/j.jmb.2021.166839.

2021-02-26

Fig 1. Landscape of mCA in the MSK-IMPACT cohort.

Fig 1. Landscape of mCA in the MSK-IMPACT cohort.
  • Gao T, Ptashkin R, Bolton KL, Sirenko M, Fong C, Spitzer B, Menghrajani K, Ossa JEA, Zhou Y, Bernard E, Levine M, Martinez JSM, Zhang Y, Franch-Exposito S, Patel M, Braunstein LZ, Kelly D, Yabe M, Benayed R, Caltabellotta NM, Philip J, Paraiso E, Mantha S, Solit DB, Diaz LA Jr, Berger MF, Klimek V, Levine RL, Zehir A, Devlin SM, Papaemmanuil E

  • Nat Commun. 2021 Jan 12;12(1):338. doi: 10.1038/s41467-020-20565-7.
Open Access button

2021-03-01

Figure 1. NRM and OS after grade 3 to 4 aGVHD, stratified by adequate CD4+ IR within the first 100 days after HCT.

Figure 1. NRM and OS after grade 3 to 4 aGVHD, stratified by adequate CD4+ IR within the first 100 days after HCT.
  • de Koning C, Prockop S, van Roessel I, Kernan N, Klein E, Langenhorst J, Szanto C, Belderbos M, Bierings M, Boulad F, Bresters D, Cancio M, Curran K, Kollen W, O'Reilly R, Scaradavou A, Spitzer B, Versluijs B, Huitema A, Lindemans C, Nierkens S, Boelens JJ

  • Blood. 2021 Feb 11;137(6):848-855. doi: 10.1182/blood.2020007905.

2021-03-02

Fig. 3. Radiation therapy trends by provider type, 2015 to 2017.

Fig. 3. Radiation therapy trends by provider type, 2015 to 2017.
  • Santos PMG, Lapen K, Zhang Z, Lobaugh S, Tsai CJ, Yang TJ, Bekelman JE, Gillespie EF

  • Int J Radiat Oncol Biol Phys. 2021 Mar 15;109(4):923-931. doi: 10.1016/j.ijrobp.2020.11.016. Epub 2020 Nov 12.

2021-03-03

Fig 2. Genomic context of SMARCA4 alterations.

Fig 2. Genomic context of SMARCA4 alterations.
  • Schoenfeld AJ, Bandlamudi C, Lavery JA, Montecalvo J, Namakydoust A, Rizvi H, Egger J, Concepcion CP, Paul S, Arcila ME, Daneshbod Y, Chang J, Sauter JL, Beras A, Ladanyi M, Jacks T, Rudin CM, Taylor BS, Donoghue MTA, Heller G, Hellmann MD, Rekhtman N, Riely GJ

  • Clin Cancer Res. 2020 Nov 1;26(21):5701-5708. doi: 10.1158/1078-0432.CCR-20-1825. Epub 2020 Jul 24.

2021-03-04

Fig 1. Disparities in incidence, preclinical models, and clinical trials of Black patients with SCLC.

Fig 1. Disparities in incidence, preclinical models, and clinical trials of Black patients with SCLC.
  • Thomas PL, Madubata CJ, Aldrich MC, Lee MM, Owonikoko TK, Minna JD, Rudin CM, Sage J, Lovly CM

  • Cancer Discov. 2021 Feb;11(2):240-244. doi: 10.1158/2159-8290.CD-20-1592. Epub 2020 Dec 14.

2021-03-05

Fig 1. Schematic illustration of RET gene rearrangements identified in non-small-cell lung cancer.

Fig 1. Schematic illustration of RET gene rearrangements identified in non-small-cell lung cancer.
  • Solomon BJ, Zhou CC, Drilon A, Park K, Wolf J, Elamin Y, Davis HM, Soldatenkova V, Sashegyi A, Lin AB, Lin BK, F Loong HH, Novello S, Arriola E, Perol M, Goto K, Santini FC

  • Future Oncol. 2021 Mar;17(7):763-773. doi: 10.2217/fon-2020-0935. Epub 2020 Nov 5.
Open Access button

2021-03-08

Fig. 1. Axial T1-weighted fat-suppressed contrast-enhanced images (left) and T2-weighted images (right) of extranodal extension (ENE).

Fig. 1. Axial T1-weighted fat-suppressed contrast-enhanced images (left) and T2-weighted images (right) of extranodal extension (ENE).
  • Mao Y, Wang S, Lydiatt W, Shah JP, Colevas AD, Lee AWM, O'Sullivan B, Guo R, Luo W, Chen Y, Tian L, Tang L, Sun Y, Liu L, Ren J, Ma J

  • Radiother Oncol. 2021 Jan 28;157:114-121. doi: 10.1016/j.radonc.2021.01.015.

2021-03-10

Figure 4. No Tumor Formation was Observed in the MSK-DA01 Tumorigenicity Study

Figure 4. No Tumor Formation was Observed in the MSK-DA01 Tumorigenicity Study
  • Piao J, Zabierowski S, Dubose BN, Hill EJ, Navare M, Claros N, Rosen S, Ramnarine K, Horn C, Fredrickson C, Wong K, Safford B, Kriks S, El Maarouf A, Rutishauser U, Henchcliffe C, Wang Y, Riviere I, Mann S, Bermudez V, Irion S, Studer L, Tomishima M, Tabar V

  • Cell Stem Cell. 2021 Feb 4;28(2):217-229.e7.

2021-03-11

Figure 2. Estimates of the number of CT scanners per million inhabitants

Figure 2. Estimates of the number of CT scanners per million inhabitants
  • Hricak H, Abdel-Wahab M, Atun R, Lette MM, Paez D, Brink JA, Donoso-Bach L, Frija G, Hierath M, Holmberg O, Khong PL, Lewis JS, McGinty G, Oyen WJG, Shulman LN, Ward ZJ, Scott AM

  • Lancet Oncol. 2021 Mar 3. pii: S1470-2045(20)30751-8. doi: 10.1016/S1470-2045(20)30751-8.

2021-03-12

Fig 4. Clonal evolution of pediatric tMN.

Fig 4. Clonal evolution of pediatric tMN.
  • Schwartz JR, Ma J, Kamens J, Westover T, Walsh MP, Brady SW, Robert Michael J, Chen X, Montefiori L, Song G, Wu G, Wu H, Branstetter C, Hiltenbrand R, Walsh MF, Nichols KE, Maciaszek JL, Liu Y, Kumar P, Easton J, Newman S, Rubnitz JE, Mullighan CG, Pounds S, Zhang J, Gruber T, Ma X, Klco JM

  • Nat Commun. 2021 Feb 12;12(1):985. doi: 10.1038/s41467-021-21255-8.
Open Access button

2021-03-15

Fig 1 Change in sun protection behavior scores at different timepoints.

Fig 1 Change in sun protection behavior scores at different timepoints.
  • Veldhuizen IJ, Schroen E, Lee EH, Kurtansky NR, Dusza SW, van der Hulst RRWJ, Pusic AL, Hoogbergen MM

  • J Cancer Educ. 2021 Feb 21. pii: 10.1007/s13187-021-01971-x. doi: 10.1007/s13187-021-01971-x.

2021-03-16

Fig. 3. Association of distance to facility and percentage of patients receiving adjuvant radiation (A) and percentage of patients receiving either brachytherapy or external-beam radiation (pelvic RT) (B). RT: radiation therapy.

Fig. 3. Association of distance to facility and percentage of patients receiving adjuvant radiation (A) and percentage of patients receiving either brachytherapy or external-beam radiation (pelvic RT) (B). RT: radiation therapy.
  • Luo LY, Aviki EM, Lee A, Kollmeier MA, Abu-Rustum NR, Tsai CJ, Alektiar KM

  • Gynecol Oncol. 2021 Feb 14. pii: S0090-8258(21)00101-3. doi: 10.1016/j.ygyno.2021.01.041.

2021-03-17

Fig. 5. Survival rescue assay for mutant clones of neoplastic tumor suppressor lgl.

Fig. 5. Survival rescue assay for mutant clones of neoplastic tumor suppressor lgl.
  • Bejarano F, Chang CH, Sun K, Hagen JW, Deng WM, Lai EC

  • Dev Biol. 2021 Mar 1;475:10-20.

2021-03-18

Figure 3e: Transjugular intrahepatic portosystemic shunt (TIPS) placement.

Figure 3e: Transjugular intrahepatic portosystemic shunt (TIPS) placement.
  • Madoff DC, Cornman-Homonoff J, Fortune BE, Gaba RC, Lipnik AJ, Yarmohammadi H, Ray CE Jr

  • Radiology. 2021 Mar;298(3):493-504. doi: 10.1148/radiol.2021201960. Epub 2021 Jan 26.

2021-03-19

Figure 2. Efficacy.

Figure 2. Efficacy.
  • Mato AR, Shah NN, Jurczak W, Cheah CY, Pagel JM, Woyach JA, Fakhri B, Eyre TA, Lamanna N, Patel MR, Alencar A, Lech-Maranda E, Wierda WG, Coombs CC, Gerson JN, Ghia P, Le Gouill S, Lewis DJ, Sundaram S, Cohen JB, Flinn IW, Tam CS, Barve MA, Kuss B, Taylor J, Abdel-Wahab O, Schuster SJ, Palomba ML, Lewis KL, Roeker LE, Davids MS, Tan XN, Fenske TS, Wallin J, Tsai DE, Ku NC, Zhu E, Chen J, Yin M, Nair B, Ebata K, Marella N, Brown JR, Wang M

  • Lancet. 2021 Mar 6;397(10277):892-901. doi: 10.1016/S0140-6736(21)00224-5.

2021-03-22

Figure 1. Plasma adenovirus viral load and treatment in 4 pediatric hematopoietic cell transplant recipients with disseminated adenovirus infection.

Figure 1. Plasma adenovirus viral load and treatment in 4 pediatric hematopoietic cell transplant recipients with disseminated adenovirus infection.
  • Chan SY, Prockop SE, Boulad F, Papanicolaou GA, Lee YJ

  • Infect Chemother. 2020 Aug 10. pii: 52.e52. doi: 10.3947/ic.2020.0204.
Open Access button

2021-03-23

Fig 1 Mechanisms by which intrinsic features promote the short-chromosome boost.

Fig 1 Mechanisms by which intrinsic features promote the short-chromosome boost.
  • Murakami H, Mu X, Keeney S

  • Curr Genet. 2021 Feb 18. pii: 10.1007/s00294-021-01160-9. doi: 10.1007/s00294-021-01160-9.

2021-03-24

Figure 1. Images show gefitinib-related pneumonitis with different CT patterns in two different patients with lung cancer.

Figure 1. Images show gefitinib-related pneumonitis with different CT patterns in two different patients with lung cancer.
  • Johkoh T, Lee KS, Nishino M, Travis WD, Ryu JH, Lee HY, Ryerson CJ, Franquet T, Bankier AA, Brown KK, Goo JM, Kauczor HU, Lynch DA, Nicholson AG, Richeldi L, Schaefer-Prokop CM, Verschakelen J, Raoof S, Rubin GD, Powell C, Inoue Y, Hatabu H

  • Chest. 2021 Mar;159(3):1107-1125. doi: 10.1016/j.chest.2020.11.027. Epub 2021 Jan 12.

2021-03-25

Figure 1. Key activities of the Project Renewal process.

Figure 1. Key activities of the Project Renewal process.
  • Kluetz PG, Keegan P, Demetri GD, Thornton K, Sul J, Kim J, Katzen H, Burke LB, Harvey RD, Alebachew E, Agrawal S, Nair A, Donoghue M, Pierce WF, Shord SS, Gao JJ, Pazdur R

  • Clin Cancer Res. 2021 Feb 15;27(4):916-921. doi: 10.1158/1078-0432.CCR-20-3213. Epub 2020 Nov 30.

2021-03-26

Fig 1. Outcomes of Diffuse Large B-Cell Lymphoma (DLBCL), Risk Factors, and Biologic Features.

Fig 1. Outcomes of Diffuse Large B-Cell Lymphoma (DLBCL), Risk Factors, and Biologic Features.
  • Sehn LH, Salles G

  • N Engl J Med. 2021 Mar 4;384(9):842-858. doi: 10.1056/NEJMra2027612.

2021-03-29

Figure 2. HMA-treatment Success OR failure status among patients with MDS.

Figure 2. HMA-treatment Success OR failure status among patients with MDS.
  • Stein EM, Bonifacio G, Latremouille-Viau D, Shi S, Guerin A, Wu EQ, Sadek I, Cao X

  • J Med Econ. 2021 Jan-Dec;24(1):234-243. doi: 10.1080/13696998.2021.1876714.
Open Access button

2021-03-30

Fig 2. Comparison plans conducted for a 76-year-old male former smoker with multifocal stage III adenocarcinoma of the right upper lobe status post right pneumonectomy with pathologic T4N2M0 disease with nodal involvement of stations 2R, 7, and 11R.

Fig 2. Comparison plans conducted for a 76-year-old male former smoker with multifocal stage III adenocarcinoma of the right upper lobe status post right pneumonectomy with pathologic T4N2M0 disease with nodal involvement of stations 2R, 7, and 11R.
  • Boyce-Fappiano D, Nguyen QN, Chapman BV, Allen PK, Gjyshi O, Pezzi TA, De B, Gomez D, Lin SH, Chang JY, Liao Z, Lee P, Gandhi SJ

  • Clin Lung Cancer. 2021 Feb 7. pii: S1525-7304(21)00025-5. doi: 10.1016/j.cllc.2021.02.002.

2021-03-31

Fig 4. Differential gene expression of tumor biopsies pre- and post-LY3022855 treatment.

Fig 4. Differential gene expression of tumor biopsies pre- and post-LY3022855 treatment.
  • Autio KA, Klebanoff CA, Schaer D, Kauh JSW, Slovin SF, Adamow M, Blinder VS, Brahmachary M, Carlsen M, Comen E, Danila DC, Doman TN, Durack JC, Fox JJ, Gluskin JS, Hoffman DM, Kang S, Kang P, Landa J, McAndrew PF, Modi S, Morris MJ, Novosiadly R, Rathkopf DE, Sanford R, Chapman SC, Tate CM, Yu D, Wong P, McArthur HL

  • Clin Cancer Res. 2020 Nov 1;26(21):5609-5620. doi: 10.1158/1078-0432.CCR-20-0855. Epub 2020 Aug 26.

2021-04-01

Figure 3: Blood counts (cells/μl) of CD27+ IgD− memory B cells (A) and CD16hi NK cells (B) in patients, stratified by relapse and maraviroc treatment.

Figure 3: Blood counts (cells/μl) of CD27+ IgD− memory B cells (A) and CD16hi NK cells (B) in patients, stratified by relapse and maraviroc treatment.
  • Pasin C, Moy RH, Reshef R, Yates AJ

  • Sci Rep. 2021 Feb 5;11(1):3230. doi: 10.1038/s41598-021-82562-0.
Open Access button